The expression of the six miRNAs were not correlated with breast cancer clinicopathological markers such as estrogen receptor expression, progesterone receptor expression, HER2 overexpression, lymphovascular invasion, and tumour grade. This evidence concerns the gene ERBB2 and neoplasm.